Enneva Therapeutics Private Limited, a active private limited company, was established on 11 November 2021 in Hyderabad, Telangana, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U24299TG2021PTC156857. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 M.
Its leadership includes Jeetendra Ambulge Kashinath (Director), Chetna Jain (Director). Past directors included Jeetendra Ambulge Kashinath, Dandu Rajgopala Raju, Gadiraju Praveen Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 8-2-293/82/F/A/18 Plot No 18 Film Nagar Jubilee Hills, Hyderabad, Telangana, 500096.
U24299TG2021PTC156857
156857
11 November 2021
₹1.00 Cr
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Enneva Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jeetendra Ambulge Kashinath | Director | 21 Sep 2024 | Current |
| Chetna Jain | Director | 21 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 03 Nov 2024 | Past |
| Pramod Abcsdd | Director | 21 Nov 2023 | Past |
| Pramod Abcsdd | Additional Director | 19 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 03 Nov 2024 | Past |
| Pramod Abcsdd | Additional Director | 19 Sep 2024 | Past |
| Pramod Abcsdd | Director | 21 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dandu Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Enneva Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Enneva Therapeutics has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Enneva Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enneva Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Enneva Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Enneva Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
The activity Jeetendra Ambulge Kashinath was appointed as a Director was appointed as a Director on 21 Sep 2024 & has been associated with this company since 1 year 3 months . was completed.
Chetna Jain was appointed as a Director was appointed as a Director on 21 Sep 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The activity Enneva Therapeutics Private Limited was registered on 11 Nov 2021 with Roc Hyderabad & aged 4 years 1 month as per MCA records. was completed.
The CIN of Enneva Therapeutics Private Limited is U24299TG2021PTC156857.
Enneva Therapeutics Private Limited is headquartered at 8-2-293/82/F/A/18 Plot No 18 Film Nagar Jubilee Hills, Hyderabad, Telangana, 500096.
Enneva Therapeutics Private Limited was incorporated on 11 November 2021.
The current directors of Enneva Therapeutics Private Limited are
The primary industry of Enneva Therapeutics Private Limited is Life Sciences.
Enneva Therapeutics Private Limited is unlisted.
The authorized capital of Enneva Therapeutics Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX